AYTU · Insider Trading
AYTU BioPharma, Inc. Common Stock
Every open-market purchase and sale reported by AYTU officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-30 | Greg Pyszczymuka | Chief Commercial Officer | A | +20,000 | — |
| 2026-07-30 | Joshua R. Disbrow | Chief Executive Officer | A | +30,000 | — |
| 2026-07-30 | John Donofrio Jr. | Director | A | +10,000 | — |
| 2026-07-30 | Vivian H Liu | Director | A | +10,000 | — |
| 2026-07-30 | Jarrett Disbrow | Chief Business Officer | A | +15,000 | — |
| 2026-07-30 | Carl Dockery | Director | A | +10,000 | — |
| 2026-07-30 | Abhinav Jain | Director | A | +10,000 | — |
| 2026-07-30 | Ryan J Selhorn | Chief Financial Officer | A | +25,000 | — |
| 2025-10-07 | Carl Dockery | Director | A | +10,000 | — |
| 2025-10-07 | Ryan J Selhorn | Chief Financial Officer | A | +33,743 | — |
| 2025-10-07 | Vivian H Liu | Director | A | +10,000 | — |
| 2025-10-07 | John Donofrio Jr. | Director | A | +10,000 | — |
| 2025-10-07 | Greg Pyszczymuka | Chief Commercial Officer | A | +12,500 | — |
| 2025-10-07 | Jarrett Disbrow | Chief Business Officer | A | +32,106 | — |
| 2025-10-07 | Abhinav Jain | Director | A | +10,000 | — |
| 2025-10-07 | Joshua R. Disbrow | Chief Executive Officer | A | +53,946 | — |
| 2025-06-10 | Jarrett Disbrow | Chief Business Officer | Buy | +16,666 | +$25.00K |
| 2025-06-10 | Joshua R. Disbrow | Chief Executive Officer | Buy | +66,666 | +$100.00K |
| 2025-06-09 | Daniel Mack | 10%+ Owner | Buy | +12,000,000 deriv. | — |
| 2025-03-31 | Greg Pyszczymuka | Chief Commercial Officer | M | +209 | — |
| 2025-03-03 | Joshua R. Disbrow | Chief Executive Officer | Buy | +15,000 | +$19.50K |
| 2025-03-03 | Ryan J Selhorn | Chief Financial Officer | M | +105 | — |
| 2025-01-02 | Greg Pyszczymuka | Chief Commercial Officer | M | +208 | — |
| 2024-11-13 | Ryan J Selhorn | Chief Financial Officer | A | +14,000 | — |
| 2024-11-08 | Jarrett Disbrow | Chief Business Officer | A | +7,000 deriv. | — |
| 2024-11-08 | Vivian H Liu | Director | A | +1,500 | — |
| 2024-11-08 | Greg Pyszczymuka | Chief Commercial Officer | A | +7,000 deriv. | — |
| 2024-11-08 | Carl Dockery | Director | A | +1,500 | — |
| 2024-11-08 | Joshua R. Disbrow | Chief Executive Officer | A | +38,000 deriv. | — |
| 2024-11-08 | Vivian H Liu | Director | A | +1,500 | — |
| 2024-11-08 | Abhinav Jain | Director | A | +1,500 | — |
| 2024-11-08 | John Donofrio Jr. | Director | A | +1,500 | — |
| 2024-10-02 | Greg Pyszczymuka | Chief Commercial Officer | M | +209 | — |
| 2024-07-02 | Greg Pyszczymuka | Chief Commercial Officer | M | +208 | — |
| 2024-06-18 | Wilmot B. Harkey | 10%+ Owner | X | — | — |
| 2024-04-02 | Greg Pyszczymuka | Chief Commercial Officer | M | +208 | — |
| 2024-01-02 | Greg Pyszczymuka | Chief Commercial Officer | M | +209 | — |
| 2023-10-03 | Greg Pyszczymuka | Chief Commercial Officer | M | +208 | — |
| 2023-08-18 | Abhinav Jain | Director | A | +6,500 | — |
| 2023-08-15 | Carl Dockery | Director | A | +1,500 | — |
| 2023-08-15 | Joshua R. Disbrow | Chief Executive Officer | A | +35,000 deriv. | — |
| 2023-08-15 | Vivian H Liu | Director | A | +1,500 | — |
| 2023-08-15 | Christopher Brooke | Chief Operating Officer | A | +7,000 deriv. | — |
| 2023-08-15 | Abhinav Jain | Director | A | +1,500 | — |
| 2023-08-15 | John Donofrio Jr. | Director | A | +1,500 | — |
| 2023-08-15 | Mark K Oki | Chief Financial Officer | A | +13,000 deriv. | — |
| 2023-08-15 | Jarrett Disbrow | Chief Business Officer | A | +7,000 deriv. | — |
| 2023-08-15 | Greg Pyszczymuka | Chief Commercial Officer | A | +7,000 deriv. | — |
| 2023-07-06 | Greg Pyszczymuka | Chief Commerical Officer | M | +208 | — |
| 2023-06-20 | Greg Pyszczymuka | Chief Commerical Officer | Buy | +12,000 | +$22.43K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Joshua R. Disbrow | Chief Executive Officer | 237,203 | $457.80K |
| Jarrett Disbrow | Chief Business Officer | 76,568 | $147.78K |
| Ryan J Selhorn | Chief Financial Officer | 74,743 | $144.25K |
| Greg Pyszczymuka | Chief Commercial Officer | 56,102 | $108.28K |
| Carl Dockery | Director | 31,162 | $60.14K |
| Vivian H Liu | Director | 29,825 | $57.56K |
| Abhinav Jain | Director | 29,500 | $56.94K |
| John Donofrio Jr. | Director | 23,762 | $45.86K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AYTU quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.